For Most Patients, Maximize Oral Lipid Therapy and Skip PCSK9s For Most Patients, Maximize Oral Lipid Therapy and Skip PCSK9s
A simulation study shows that for 86% of patients who require cholesterol lowering, statins and ezetimibe are sufficient, while the remaining 14% will need add-on PCSK9 inhibitors to reach target LDL levels.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 14, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news
Forget PCSK9 Drugs? Almost All Could Reach Target LDL With Oral Agents (CME/CE)
Debate is done (MedPage Today) -- focus on intense statin and ezetimibe use, groups argue (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 3, 2017 Category: Cardiology Source Type: news
High-fat diet leads to same intestinal inflammation as a virus
FINDINGSA new study by scientists at UCLA found that when mice eat a high-fat diet, the cells in their small intestines respond the same way they do to a viral infection, turning up production of certain immune molecules and causing inflammation throughout the body. The scientists also found that feeding the mice tomatoes containing a protein similar to that in HDL, or “good cholesterol,” along with the generic cholesterol drug Ezetimibe, reversed the inflammation.The results could lead to new types of drugs, targeting the intestinal cells, to reduce people ’s risk of heart attacks and strokes, or to treat other cond...
Source: UCLA Newsroom: Health Sciences - June 21, 2017 Category: Universities & Medical Training Source Type: news
Sun Pharma receives USFDA nod for anti-cholesterol drug
"As per IMS, ezetimibe tablets had annual sales of approximately USD 2.7 billion in the US for the 12 months ended April 2017," it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 13, 2017 Category: Pharmaceuticals Source Type: news
Zydus Cadila gets USFDA nod for ezetimibe tablets
The group now has around 115 approvals from USFDA and has so far filed 300 abbreviated new drug applications (ANDAs), the company said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 13, 2017 Category: Pharmaceuticals Source Type: news
Teva launches generic version of Merck cholesterol-lowering medicine
Teva Pharmaceutical Industries Ltd. said Monday it has launched a generic version of the cholesterol lowering medication Zetia.
Zetia, which contains the active ingredient ezetimibe, is a prescription medicine made by Merck (NYSE: MRK) used to lower levels of total cholesterol and low-density lipoprotein (LDL) cholesterol in the blood. Ezetimibe tablets are for patients who cannot control their cholesterol levels by diet a nd exercise alone. Teva said the product can be used by itself or with other… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 12, 2017 Category: Biotechnology Authors: John George Source Type: news
Teva launches generic version of Merck cholesterol-lowering medicine
Teva Pharmaceutical Industries Ltd. said Monday it has launched a generic version of the cholesterol lowering medication Zetia.
Zetia, which contains the active ingredient ezetimibe, is a prescription medicine made by Merck (NYSE: MRK) used to lower levels of total cholesterol and low-density lipoprotein (LDL) cholesterol in the blood. Ezetimibe tablets are for patients who cannot control their cholesterol levels by diet a nd exercise alone. Teva said the product can be used by itself or with other… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 12, 2017 Category: American Health Authors: John George Source Type: news
Generic Vytorin to Hit U.S. Market (FREE)
By the Editors
Clinicians may soon be able to prescribe generic Vytorin (ezetimibe/simvastatin) … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - April 28, 2017 Category: Primary Care Source Type: news
Dr Reddy's launches cholesterol lowering drug in US
The company has launched Ezetimibe and Simvastatin tablets in the strengths of 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg in the US market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 27, 2017 Category: Pharmaceuticals Source Type: news
Merck cholesterol drug Vytorin faces competition from Impax, Teva generics
(Reuters) - Merck& Co's cholesterol-reducing drug Vytorin faces competition for the first time ever after two companies announced progress on their generic versions of a drug that generated more than $1 billion in sales last year. (Source: Reuters: Health)
Source: Reuters: Health - April 26, 2017 Category: Consumer Health News Tags: healthNews Source Type: news
Impax Announces FDA Approval and Launch of a Generic Version of Vytorin(R) (Ezetimibe/Simvastatin Tablets)
HAYWARD, Calif., April 26, 2017 -- (Healthcare Sales & Marketing Network) -- Impax Laboratories, Inc. (NASDAQ: IPXL), a specialty pharmaceutical company, today announced it has received final U.S. Food and Drug Administration (FDA) approval for a generic ... Biopharmaceuticals, Generics, FDA, Product Launch Impax Laboratories, Vytorin, ezetimibe, simvastatin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 26, 2017 Category: Pharmaceuticals Source Type: news
Vytorin (Ezetimibe and Simvastatin) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 3, 2017 Category: Drugs & Pharmacology Source Type: news
Glenmark launches generic version of Zetia in US market
"We have launched ezetimibe, the first and only generic version of Zetia (Merck) in the United States for the treatment of high cholesterol," (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 12, 2016 Category: Pharmaceuticals Source Type: news
Liptruzet (Ezetimibe and Atorvastatin Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 9, 2016 Category: Drugs & Pharmacology Source Type: news
Zetia (Ezetimibe Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 12, 2016 Category: Drugs & Pharmacology Source Type: news
